Skip to main content
Top
Published in: Diabetologia 8/2003

01-08-2003 | Article

The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

Authors: K. Sadeharju, M. Knip, M. Hiltunen, H. K. Åkerblom, H. Hyöty

Published in: Diabetologia | Issue 8/2003

Login to get access

Abstract

Aims/hypothesis

Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes.

Methods

Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles.

Results

Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele (p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) (p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects).

Conclusions/interpretation

Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
Literature
1.
go back to reference D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed
2.
go back to reference Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed
3.
go back to reference Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed
4.
go back to reference Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed
5.
go back to reference Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed
6.
go back to reference Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed
7.
go back to reference Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632 Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632
8.
go back to reference Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed
9.
go back to reference Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139 Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139
10.
go back to reference Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis) Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis)
11.
go back to reference Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed
12.
go back to reference Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed
13.
go back to reference Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed
14.
go back to reference Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed
15.
go back to reference Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302 Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302
16.
go back to reference Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed
17.
go back to reference Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed
18.
19.
go back to reference Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef
20.
go back to reference Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed
21.
go back to reference Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed
22.
go back to reference Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed
23.
go back to reference Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23 Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23
24.
go back to reference Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed
Metadata
Title
The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens
Authors
K. Sadeharju
M. Knip
M. Hiltunen
H. K. Åkerblom
H. Hyöty
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1157-x

Other articles of this Issue 8/2003

Diabetologia 8/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.